McKesson and Cardinal Health Extend Distribution Deals with CVS Health Through 2032
Key Facts
McKesson and Cardinal Health announced the extension of their existing pharmaceutical distribution agreements with CVS Health. Seeking Alpha reported that these extensions will run through June 2032, ensuring continuity in the pharmaceutical supply chain between the major distributors and one of the largest pharmacy chains in the US.
MCK closed at $853.81 and CAH closed at $222.50 on September 30, 2026, while CVS finished the same session at $85.69. These extensions are expected to secure long-term revenue stability for the distributors, who both reaffirmed their fiscal year 2027 guidance following the announcement.
Latest Updates · 1
- Notable·
Update: McKesson stock rose 4.52% during trading on October 1, 2026, as investors reacted positively to the distribution contract extension. This price movement follows the company's confirmation of its long-term strategic partnership with CVS Health.